Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IDP-126 Gel in moderate to severe acne vulgaris
NCT04892706Phase 2Completed
- Sponsor
- Valeant Pharmaceuticals
- Start
- Jun 2021
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of clindamycin phosphate + adapalene + benzoyl peroxide in acne vulgaris, sponsored by Valeant Pharmaceuticals. Started Jun 2021; status: completed.
02
Drugs
clindamycin phosphate + adapalene + benzoyl peroxide
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT04892706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04892706.